Obesity Survey Results Obesity is a multi-factorial, chronic, relapsing disease that occurs when a person has an excessive amount of body fat (adipose tissue) that might increase health complications. Obesity is defined as having a body mass index (BMI) of 30 kg/m2 or greater. Over the past few decades, obesity has become increasingly common in [...]
SURVEY CLOSED C. difficile Survey (CLOSED) The Gastrointestinal Society represents patients with gastrointestinal diseases and disorders on a variety of health care fronts. We have designed this survey to help us understand your opinions and outlook regarding the effects that infection with the C. difficile bacterium has on the lives of patients. We will use [...]
Survey Results: Biosimilars The Gastrointestinal Society represents inflammatory bowel disease (IBD) patients on a variety of health care fronts, including access to medications. During the first part of 2015, we hosted a survey on our English (www.badgut.org) & French (www.mauxdeventre.org) websites to help understand IBD patients’ opinions and outlooks regarding biosimilars (subsequent entry biologics/SEBs). To [...]
Attention Canadian patients who have inflammatory bowel disease (IBD): Crohn’s disease and ulcerative colitis. THIS SURVEY IS CLOSED Janssen Canada has engaged a third party to conduct a survey to learn about your opinions and experiences regarding therapies for IBD. They will use the data in aggregate and Janssen will not receive any of your [...]
Call for Patient Perspectives - Constella® for Chronic Constipation The Gastrointestinal Society is looking for details of patients’ experiences using Constella®. We invite Canadians with a history of chronic constipation who have used Constella® (linaclotide) to complete this brief survey. We will use this information in aggregate as the GI Society advocates on behalf of [...]
Call for Patient Perspectives - Ulcerative Colitis SURVEY CLOSED The Gastrointestinal Society is looking for details of Canadian patients’ experiences with ulcerative colitis (UC). We will use this information in aggregate in our patient advocacy activities, including patient group submissions for drug coverage, public awareness campaigns, and other relevant initiatives. The GI Society is a [...]
